会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • The use of lipoxygenase and cyclooxygenase inhibitors as synergistic agents
    • 使用脂氧合酶和环氧合酶抑制剂作为协同剂
    • EP0485111A2
    • 1992-05-13
    • EP91310059.0
    • 1991-10-31
    • ZENECA LIMITEDICI PHARMA
    • Foster, Stephen John
    • A61K31/535A61K31/47A61K31/35
    • A61K31/35A61K31/47A61K31/535A61K31/405A61K31/195A61K31/19A61K2300/00
    • The invention relates to synergistic agents for the treatment of inflammatory or arthritic conditions which comprise one of a selected group of inhibitors of the enzyme 5-lipoxygenase in conjunction or admixture with an inhibitor of the enzyme cyclooxygenase. Conveniently the 5-lipoxygenase inhibitor is, for example, 6-[(3-fluoro-5-[4-methoxy-3,4,5,6-tetrahydro-2 H -pyran-4-yl]phenoxy)methyl]-1-methyl-2-quinolone or 4-[5-fluoro-3-(4-methyl-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-7-ylthio)phenyl]-4-methoxytetrahydropyran and the cyclooxygenase inhibitor is selected from indomethacin, flurbiprofen and diclofenac. The invention also relates to a pharmaceutical composition containing said synergistic agent and to the use of said agent in the manufacture of a medicament for the synergistic treatment of inflammatory or arthritic disease.
    • 本发明涉及用于治疗炎性或关节炎病症的协同剂,其包含选择的5-脂氧合酶抑制剂中的一种与酶环加氧酶的抑制剂结合或混合。 方便地,5-脂肪氧合酶抑制剂是例如6 - [(3-氟-5- [4-甲氧基-3,4,5,6-四氢-2H-吡喃-4-基]苯氧基)甲基] -1 2-甲基-2-喹啉酮或4- [5-氟-3-(4-甲基-3-氧代-2,3-二氢-4H-1,4-苯并恶嗪-7-基硫基)苯基] -4-甲氧基四氢吡喃和 环加氧酶抑制剂选自吲哚美辛,氟比洛芬和双氯芬酸。 本发明还涉及含有所述增效剂的药物组合物以及所述试剂在制备用于协同治疗炎症或关节炎疾病的药物中的用途。
    • 10. 发明公开
    • Bicyclic derivatives
    • Bizyklische Derivate。
    • EP0410661A2
    • 1991-01-30
    • EP90308023.2
    • 1990-07-23
    • IMPERIAL CHEMICAL INDUSTRIES PLCICI PHARMA
    • Bird, Thomas Geoffrey ColerickKingston, John Francis, 24 Cornfield CloseWaterson, David
    • C07D407/04C07D317/46A61K31/36
    • C07D407/04C07D317/46
    • The invention concerns a bicyclic derivative of the formula I, or a pharmaceutically-acceptable salt thereof.
      wherein Ar¹ is optionally substituted phenyl or naphthyl;
      R¹ if (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and
      R² and R³ together form a group of the formula -A¹-X-A²-, wherein each of A¹ and A² is (1-4C)alkylene and X is oxy, thio, sulphinyl, sulphonyl or imino.
      The invention also concerns processes for the manufacture of a bicyclic derivative of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said bicyclic derivatives. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
    • 本发明涉及式I的双环衍生物或其药学上可接受的盐。 其中Ar 1是任选取代的苯基或萘基; (1-6C)烷基,(3-6C)烯基,(3-6C)炔基,氰基 - (1-4C)烷基或(2-4C)烷酰基或任选取代的苯甲酰基; 和R 2和R 3一起形成式-A 1 -XA 2 - 的基团,其中A 1和A 2各自为(1-4C)亚烷基和X 是氧基,硫基,亚磺酰基,磺酰基或亚氨基。 本发明还涉及制备式I的双环衍生物或其药学上可接受的盐以及含有所述双环衍生物的药物组合物的方法。 本发明的化合物是5-脂氧合酶的抑制剂。